Challenges and opportunities in defining the essential cancer kinome

Brendan D Manning1

  • 1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA. bmanning@hsph.harvard.edu

Science Signaling
|March 26, 2009
PubMed

Insights

Protein kinases are key in cancer, but current therapies target only a few. RNA interference screens reveal diverse kinase dependencies in cancer cells, highlighting many unexploited therapeutic targets.

Area of Science:

  • * Molecular Biology
  • * Oncology
  • * Genetics

Background:

  • * Protein kinases are crucial signaling molecules involved in numerous human diseases, including cancer.
  • * Current cancer therapeutics primarily target a limited subset of protein kinases, overlooking broader potential.
  • * Cancer cell lines exhibit significant diversity in their reliance on specific protein kinases for survival and proliferation.

Purpose of the Study:

  • * To investigate the landscape of protein kinase dependencies across different cancer cell lines.
  • * To identify previously uncharacterized protein kinases essential for cancer cell proliferation and survival.
  • * To explore novel therapeutic strategies by uncovering unexploited kinase targets.

Main Methods:

  • * Genome-wide RNA interference (RNAi) screens were employed to assess protein kinase requirements.
  • * Kinome-specific RNAi screens were conducted to analyze dependencies across the entire protein kinase family.
  • * Comparative analysis of kinase dependencies was performed across various cancer cell lines.

Main Results:

  • * RNAi screens revealed substantial heterogeneity in cancer cell line dependence on specific protein kinases.
  • * Critical protein kinases for cancer cell proliferation and survival were identified, many of which are understudied.
  • * Unbiased screens identified novel, potentially targetable protein kinases beyond the commonly studied ones.

Conclusions:

  • * Protein kinase dependencies in cancer are more diverse than previously assumed.
  • * Targeting understudied protein kinases represents a promising avenue for novel cancer therapeutics.
  • * Unbiased kinome-wide screens are essential for discovering new therapeutic interventions in oncology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...